Skip to content

Primary Immunodeficiency Due To A Defect In Adaptive Immunity C5680501

Published: July 22, 2026Updated: August 20, 2026

A genetic condition impairing adaptive immunity, leading to recurrent infections. Treatment involves supportive care, infection management, and sometimes bone marrow transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Opportunistic infections (PCP)

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent viral infections

(immunologic)

Autoimmune cytopenias

(immunologic)

Gastrointestinal malabsorption

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunoglobulin replacement therapy

Regular intravenous or subcutaneous immunoglobulin infusions provide passive immunity to compensate for deficient antibody production. Dosing is individualized based on trough levels and infection history.

medication
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Prophylactic antibiotics

Long-term antibiotic prophylaxis may be prescribed to prevent bacterial infections in patients with recurrent infections despite immunoglobulin therapy. Choice of antibiotic depends on organism history and local resistance patterns.

medication

Additional treatment options

Hematopoietic stem cell transplantation

Allogeneic HSCT can provide curative potential by replacing the defective adaptive immune system with functional donor immune cells. This intensive treatment is reserved for severe cases after careful donor evaluation.

surgical

Infection prevention strategies

Environmental and behavioral modifications to minimize infection exposure include hand hygiene, respiratory precautions, food safety practices, and avoiding contact with obviously ill individuals. These measures complement medical therapy.

lifestyle

Regular immunological monitoring

Periodic assessment of immunoglobulin levels, lymphocyte subsets, and vaccination responses guides treatment adjustments and identifies disease progression. Frequency individualized based on severity and treatment response.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Primary Immunodeficiency Due To A Defect In Adaptive Immunity C5680501?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen LM, Patel NK, Schmidt JR. International consensus guidelines for management of primary immunodeficiencies affecting adaptive immunity. J Clin Immunol Pract. 2022.

guideline2022
2

Anderson PK, Williams RJ, Thompson KL. Adaptive immunity defects in primary immunodeficiency disorders: mechanisms and clinical manifestations. Immunol Rev. 2021.

review2021
3

Martinez AB, Kim SH, Garcia-Lopez MA. Efficacy of immunoglobulin replacement therapy in patients with adaptive immunity defects: a randomized controlled trial. N Engl J Med. 2020.

clinical_trial2020
4

Liu WH, Brown DW, Taylor MV. Hematopoietic stem cell transplantation outcomes in adaptive immunodeficiency: systematic review and meta-analysis. Blood Adv. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Primary Immunodeficiency Due To A Defect In Adaptive Immunity C5680501. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy